Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer

Affiliations

¹ Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
² Computational and Experimental Biology Group, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisbon, Portugal.
³ Hospitais Cuf, Coimbra, Portugal.
⁴ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
⁵ Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Rui Bernardino et al. BJU Int. 2023 Dec.

. 2023 Dec;132(6):638-640.

doi: 10.1111/bju.16162. Epub 2023 Aug 31.

¹ Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
² Computational and Experimental Biology Group, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisbon, Portugal.
³ Hospitais Cuf, Coimbra, Portugal.
⁴ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
⁵ Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

No abstract available

References

1. Cooperberg MR, Hilton JF, Carroll PR. The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer 2011; 117: 5039-5046
1. Ericson KJ, Wu SS, Lundy SD, Thomas LJ, Klein EA, McKenney JK. Diagnostic accuracy of prostate biopsy for detecting cribriform Gleason pattern 4 carcinoma and Intraductal carcinoma in paired radical prostatectomy specimens: implications for active surveillance. J Urol 2020; 203: 311-319
1. Remmers S, Helleman J, Nieboer D et al. Active surveillance for men younger than 60 years or with intermediate-risk localized prostate cancer. Descriptive analyses of clinical practice in the Movember GAP3 initiative. Eur Urol Open Sci 2022; 41: 126-133
1. Kim SP, Shah ND, Meropol NJ et al. Recommendations of active surveillance for intermediate-risk prostate cancer: results from a national survey of radiation oncologists and urologists. Eur Urol Oncol 2019; 2: 189-195
1. Becerra MF, Bhat A, Mouzannar A, Atluri VS, Punnen S. Serum and urinary biomarkers for detection and active surveillance of prostate cancer. Curr Opin Urol 2019; 29: 593-597